Deconvoluting inflammation and immunology for clinical trials
Inflammation is a complex biological process involving a host of resident and recruited immune cells which are mobilized to infiltrate tissues in response to invading pathogens. These immune cells boast elevated numbers and heightened activation as they churn out inflammatory mediators, which act in unison to coordinate and modulate the immune response.
Choosing the right bioanalytical platform for your immunology clinical trial is critical to data collection. But navigating the intricate inflammation process can be difficult. What do these platforms look like in use, and how should you go about selecting the right one?
This webinar will identify the most common bioanalytical platforms used during clinical trials to measure levels of inflammatory mediators in biological fluids. Using SARS-COV-2 samples, we will go over a custom 10 analyte inflammatory panel and identify how the levels observed for these mediators in Covid patients compare with an uninfected patient's matrix. We will also discuss how these platforms measure specific immunological markers in clinical trial subjects by flow cytometry.
